PFKFB3 inhibition/silencing indeed leads to a decrease in F-2,6-BP, subsequently reducing glycolysis and resulting in an inhibition of tumor growth and an induction of cancer cell death (Chesney et al., 1999; Seo et al., 2011; Clem et al., 2008). This evidence concerns the gene PFKFB3 and cancer.